These benefits, together with a earlier report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 help the strategy of focusing on ACKR3 as a unique way to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar disorders. Note: Final results may https://bethi495ctj0.targetblogs.com/profile